Reliable technology for reproducible results

IMPACT centrifuges and separates the requested blood fractions fully automated and in a closed system. The integral optical sensor separates reliably and precisely. The syringe with the patient’s blood is laid in, and after the program has been completed, the requested autologous blood product is removed and “ready-to-use”.

IMPACT PLATFORM

ONE SYSTEM – MANY THERAPEUTIC OPTIONS

The innovative technology of IMPACT permits the preparation of variable concentrations of leukocytes and thrombocytes. And that, by means of a very simple automated preparation process. Scientifically tested IMPACT programs with specific parameters are recommended for each therapeutic goal. In addition, the system also permits the physician to define and store own program variants.
Modern personalized medicine to customize treatment options to each patient‘s needs.

RELIABLE TECHNOLOGY FOR REPRODUCIBLE RESULTS

IMPACT centrifuges and separates the requested blood fractions fully automated and in a closed system. The integral optical sensor separates reliably and precisely. The syringe with the patient’s blood is laid in, and after the program has been completed, the requested autologous blood product is removed and “ready-to-use”.

The IMPACT technology ensures:

• high therapeutic safety
• reliable results for reproducible product quality
• excellent cell yield

Very Easy handling

Blood collection: 12 ml of whole blood

Connect the syringe filled with whole blood to the empty IMPACT syringe
using the tube included in
the therapy set

Place the connected syringes (so-called tandem) into the rotor If needed, place a second tandem

One or two centrifugation cycles depending on program selected and automated seperation of requested
cell therapy

Once program completed, remove the syringes Detach the syringe with the autologous ready-to-use blood product

Injection to the defect site

This content requires cookies
PGlmcmFtZSB3aWR0aD0iNzAwIiBoZWlnaHQ9IjM2MCIgc3JjPSJodHRwczovL3d3dy55b3V0dWJlLmNvbS9lbWJlZC9fNk14ZzJpUEZjNCIgdGl0bGU9IklNUEFDVMKuIC0gUHJvZHVjdCBQcmV2aWV3IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3c9ImFjY2VsZXJvbWV0ZXI7IGF1dG9wbGF5OyBjbGlwYm9hcmQtd3JpdGU7IGVuY3J5cHRlZC1tZWRpYTsgZ3lyb3Njb3BlOyBwaWN0dXJlLWluLXBpY3R1cmUiIGFsbG93ZnVsbHNjcmVlbj48L2lmcmFtZT4=

Technical data

Dimensions (H × W × D): 456 x 555 x 707 mm
Capacity: 2 x 12 ml
Max. RPM: 2.800
Max. RCF: 940
Intuitive user-friendly touch display for easy operation


THE IMPACT SYSTEM AND ITS UNIQUE BENEFITS

SUPERIOR HANDLING

  • Fully automated system
  • Fast processing time
  • Product/therapy is ready-to-use straight out of the centrifuge

TOP RESULTS WITH HIGH REPRODUCIBILITY 1

  • High platelet yield
  • High yield of growth factors and anti-inflammatory cytokines
  • Presence and absence of leukocytes determined by user
  • Adjustable final volume

HIGH FLEXIBILITY

  • A multitude of different autologous cell therapies with just one system
  • Physicians can save their own individualized programs
  • Use across medical specialties

EXCELLENT SAFETY

  • Closed system
  • Scientifically tested IMPACT programs 1
  • Reliability and quality Made in Germany

1 Scientifically tested serum concentrations (TU Munich)

THE IMPACT sets

ONE SYSTEM – MANY THERAPEUTIC OPTIONS

The IMPACT system can be used to prepare a number of different autologous cell therapies at the push of a button. The selection is
made depending on the respective therapeutic objective. Single-use sets are available for different therapeutic applications:

IMPACT PRP – Platelet Rich Plasma
Without anticoagulant for the production of slightly concentrated platelet-rich plasma

IMPACT APC – Autologous Platelet Concentrate
With anticoagulant for the production of highly concentrated platelet concentrate

IMPACT ACS – Autologous Conditioned Serum
For the production of an autologous conditioned serum

IMPACT BMC – Bone Marrow Concentrate
For the production of bone marrow aspirate concentrate